| 
ARTICLE
Two phase I studies of low dose recombinant human IL-12 with
Melan-A and influenza peptides in subjects with advanced malignant
melanoma
Jonathan Cebon, Elke Jäger, Mark J. Shackleton, Peter Gibbs, Ian
D. Davis, Wendie Hopkins, Sharen Gibbs, Qiyuan Chen, Julia Karbach,
Heather Jackson, Duncan P. MacGregor, Sue Sturrock, Hilary Vaughan,
Eugene Maraskovsky, Antje Neumann, Eric Hoffman, Mathew L. Sherman,
and Alexander Knuth
Cancer Immunity 3 : 7 (16 July 2003) >Abstract
>Full text >PDF
ARTICLE
Ex vivo detectable activation of Melan-A-specific T
cells correlating with inflammatory skin reactions in melanoma
patients vaccinated with peptides in IFA
Danielle Liénard, Donata Rimoldi, Marie Marchand, Pierre-Yves
Dietrich, Nicolas van Baren, Christine Geldhof, Pascal Batard,
Philippe Guillaume, Maha Ayyoub, Mikaël J. Pittet, Alfred
Zippelius, Katharina Fleischhauer, Ferdy Lejeune, Jean-Charles
Cerottini, Pedro Romero, and Daniel E. Speiser
Cancer Immunity 4 : 4 (19 May 2004) >Abstract
>Full text >PDF
ARTICLE
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L),
on the immunogenicity of melanoma peptide vaccination with adjuvant
Flt3 ligand
Mark Shackleton, Ian D. Davis, Wendie Hopkins, Heather Jackson,
Nektaria Dimopoulos, Tsin Tai, Qiyuan Chen, Phillip Parente, Michael
Jefford, Kelly-Anne Masterman, Dania Caron, Weisan Chen, Eugene
Maraskovsky, and Jonathan Cebon
Cancer Immunity 4 : 9 (23 September 2004) >Abstract
>Full text >PDF
ARTICLE
Humoral immune response in prostate cancer patients after immunization
with gene-based vaccines that encode for a protein that is proteasomally
degraded
Krasimira Todorova, Irena Ignatova, Stoyan Tchakarov, Iskra Altankova,
Serguei Zoubak, Stanimir Kyurkchiev, and Milcho Mincheff
Cancer Immunity 5 : 1 (11 January 2005) >Abstract
>Full text >PDF
ARTICLE
Immunological effects of chimeric anti-GD3 monoclonal antibody
KM871 in patients with metastatic melanoma
Andrew M. Scott, Zhanqi Liu, Carmel Murone, Terrance G. Johns,
Duncan MacGregor, Fiona E. Smyth, Fook-Thean Lee, Jonathan Cebon,
Ian D. Davis, Wendie Hopkins, Angela J. Mountain, Angela Rigopoulos,
Nobuo Hanai, and Lloyd J. Old
Cancer Immunity 5 : 3 (22 February 2005) >Abstract
>Full text >PDF
ARTICLE
Characterization
of antigen-specific CD8+ T lymphocyte responses in skin and peripheral
blood following intradermal peptide vaccination
Qiyuan Chen, Heather Jackson, Mark Shackleton, Phillip Parente,
Wendie Hopkins, Sue Sturrock, Duncan MacGregor, Eugene Maraskovsky,
Tsin Yee Tai, Nektaria Dimopoulos, Kelly-Anne Masterman, Tina
Luke, Ian D. Davis, Weisan Chen, and Jonathan Cebon
Cancer Immunity 5 : 5 (9 March 2005) >Abstract
>Full text >PDF
ARTICLE
Effects of desialylation of ovine submaxillary gland mucin
(OSM) on humoral and cellular immune responses to Tn and sialylated
Tn
Kevin P. O'Boyle, Susan Coatsworth, Gillian Anthony, Mark Ramirez,
Edward Greenwald, Ronald Kaleya, Jacob J. Steinberg, Janice P.
Dutcher, and Peter H. Wiernik
Cancer Immunity 6 : 5 (9 March 2006) >Abstract
>Full text >PDF
ARTICLE
T cell immunomonitoring and tumor responses in patients immunized
with a complex of cholesterol-bearing hydrophobized pullulan (CHP)
and NY-ESO-1 protein
Akiko Uenaka, Hisashi Wada, Midori Isobe, Takashi Saika, Kazuhide
Tsuji, Eiichi Sato, Shuichiro Sato, Yuji Noguchi, Ryohei Kawabata,
Takushi Yasuda, Yuichiro Doki, Hiromi Kumon, Keiji Iwatsuki, Hiroshi
Shiku, Morito Monden, Achim A. Jungbluth, Gerd Ritter, Roger Murphy,
Eric Hoffman, Lloyd J. Old and Eiichi Nakayama
Cancer Immunity 7 : 9 (19 April 2007) >Abstract
>Full text >PDF
ARTICLE
A phase I multiple dose, dose escalation study of cG250 monoclonal
antibody in patients with advanced renal cell carcinoma
Ian D. Davis, Gregory A. Wiseman, Fook-Thean Lee, Denise N. Gansen,
Wendie Hopkins, Anthony T. Papenfuss, Zhanqi Liu, Timothy J. Moynihan,
Gary A. Croghan, Alex A. Adjei, Eric W. Hoffman, James N. Ingle,
Lloyd J. Old and Andrew M. Scott
Cancer Immunity 7 : 13 (17 August 2007) >Abstract
>Full text >PDF
ARTICLE
LUD 00-009: Phase 1 study of intensive course immunization
with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing
cancer
Armin Bender, Julia Karbach, Antje Neumann, Dirk Jäger, Salah
E. Al-Batran, Akin Atmaca, Eckhart Weidmann, Melina Biskamp, Sacha
Gnjatic, Linda Pan, Eric Hoffman, Lloyd J. Old, Alexander Knuth
and Elke Jäger
Cancer Immunity 7 : 16 (19 October 2007) >Abstract
>Full text >PDF
ARTICLE
Preoperative treatment with a non-steroidal anti-inflammatory
drug (NSAID) increases tumor tissue infiltration of seemingly
activated immune cells in colorectal cancer
Christina Lönnroth, Marianne Andersson, Annette Arvidsson,
Svante Nordgren, Hans Brevinge, Kristina Lagerstedt and Kent Lundholm
Cancer Immunity 8 : 5 (29 February 2008) >Abstract
>Full text >PDF
ARTICLE
Safety and immunogenicity of a human and mouse gp100 DNA vaccine
in a phase I trial of patients with melanoma
Jianda Yuan, Geoffrey Y. Ku, Humilidad F. Gallardo, Francesca
Orlandi, Gregor Manukian, Teresa S. Rasalan, Yinyan Xu, Hao Li,
Shachi Vyas, Zhenyu Mu, Paul B. Chapman, Susan E. Krown, Katherine
Panageas, Stephanie L. Terzulli, Lloyd J. Old, Alan N. Houghton
and Jedd D. Wolchok
Cancer Immunity 9 : 5 (5 June 2009) >Abstract
>Full text >PDF |
